You have 9 free searches left this month | for more free features.

Metformin 500 mg Prolonged Release Tablets

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pharmacokinetics Trial in Prague (Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Pharmacokinetics Trial in Prague (Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 9, 2021

Preeclampsia Trial in Sweden (Metformin ER, Placebo)

Not yet recruiting
  • Preeclampsia
  • Metformin ER
  • Placebo
  • Falun, Sweden
  • +5 more
Sep 10, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Drug Use Trial in Jakarta Pusat (Metformin Hydrochloride 500 MG)

Completed
  • Drug Use
  • Metformin Hydrochloride 500 MG
  • Jakarta Pusat, DKI Jakarta, Indonesia
    PT Pharma Metric Labs
Feb 21, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Knee Osteoarthritis, Metformin Trial in Dhaka (Metformin 500 Mg extended release Oral Tablet, Placebo oral tablet)

Recruiting
  • Knee Osteoarthritis
  • Metformin
  • Metformin 500 Mg extended release Oral Tablet
  • Placebo oral tablet
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Nov 13, 2023

Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)

Completed
  • Healthy
  • Glucophage® XR Test
  • Glucophage® XR Reference
  • Daejeon, Korea, Republic of
    Clinical Trials Center, Chungnam National University Hospital
Mar 30, 2022

Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)

Recruiting
  • Healthy
  • Test Glucophage® XR
  • Reference Glucophage® XR
  • Darmstadt, Germany
    Research Site
Aug 10, 2022

Epilepsy, Lamotrigine, Sodium Valproate Adverse Reaction Trial (Sodium Valproate 500 Mg Prolonged-Release Oral Tablet,

Not yet recruiting
  • Epilepsy
  • +2 more
  • Sodium Valproate 500 Mg Prolonged-Release Oral Tablet
  • +2 more
  • (no location specified)
May 20, 2023

Healthy Trial in Arzo (Trazodone HCl - new polymer, Trazodone HCl - Contramid®)

Completed
  • Healthy
  • Trazodone HCl - new polymer
  • Trazodone HCl - Contramid®
  • Arzo, Switzerland
    CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone:
Nov 15, 2021

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
  • Placebo oral tablet identical to metformin, up to 4 tablets a day
  • Los Angeles, California
    University of California, Los Angeles
May 2, 2022

Lower Urinary Tract Symptoms, Voiding Disorders, Pain Trial in Split (Tadalafil 5mg, Tamsulosin Hydrochloride 400 Microgram

Enrolling by invitation
  • Lower Urinary Tract Symptoms
  • +3 more
  • Tadalafil 5mg
  • +2 more
  • Split, Splitsko-dalmatinska, Croatia
    University hospital of Splity
Sep 11, 2022

Glucocorticoid Effect Trial in Basel (Metformin 500 mg Oral Tablets + Prednisone 20mg Tablets, Placebo 500 mg Tablets +

Completed
  • Glucocorticoid Effect
  • Metformin 500 mg Oral Tablets + Prednisone 20mg Tablets
  • Placebo 500 mg Tablets + Prednisone 20mg Tablets
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel
Sep 22, 2021

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Toluca Lake, California
  • +101 more
Oct 9, 2023

Type 2 Diabetes Trial in Nakhon Pathom (Gemigliptin tartrate sesquihydrate and metformin, gemigliptin 50 mg and metformin HCl

Completed
  • Type 2 Diabetes
  • Gemigliptin tartrate sesquihydrate and metformin
  • gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
  • Nakhon Pathom, Thailand
    International Bio Service Co., Ltd.
Feb 4, 2021

Polycystic Ovary Syndrome (PCOS) Trial in Al Madinah (Metformin Versus a combination of Metformin and Thymoquinone (TQ))

Completed
  • Polycystic Ovary Syndrome (PCOS)
  • Metformin Versus a combination of Metformin and Thymoquinone (TQ)
  • Al Madīnah, Madinah, Saudi Arabia
    Saudi German Hospital
Apr 17, 2021

Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))

Not yet recruiting
  • Thyroid Cancer
  • Bialystok, Poland
    Department of Endocrinology, Diabetology and Internal Medicine,
Jul 26, 2022

Polycystic Ovary Syndrome Trial in Al Qadisiyah (Metformin Hydrochloride 500 MG, Cabergoline 0.5 MG, Metformin Hydrochloride 500

Completed
  • Polycystic Ovary Syndrome
  • Metformin Hydrochloride 500 MG
  • +2 more
  • Al Qādisīyah, Al-Qādisiyyah Governorate, Iraq
    Maternity and Pediatric Teaching Hospital
Jul 31, 2023

Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)

Recruiting
  • Multiple Sclerosis
  • Metformin and clemastine in combination
  • Placebo
  • Cambridge, United Kingdom
    Addenbrooke's Hospital
Jun 14, 2022